               SEQUENCE LISTING

<110> ISIN S.A.

<120> Compositions for enhancing skin antimicrobial defence

<130> P1892EP00

<160> 6

<170> BiSSAP 1.0

<210> 1
<211> 22
<212> DNA
<213> artificial sequences

<220> 
<221> source
<222> 1..22
<223> /mol_type="DNA"
      /note="18S rRNA forward primer"
      /organism="artificial sequences"

<400> 1
gccgctagag gtgaaattct tg                                             22


<210> 2
<211> 21
<212> DNA
<213> artificial sequences

<220> 
<221> source
<222> 1..21
<223> /mol_type="DNA"
      /note="18S rRNA reverse primer"
      /organism="artificial sequences"

<400> 2
cattcttggc aaatgctttc g                                              21


<210> 3
<211> 22
<212> DNA
<213> artificial sequences

<220> 
<221> source
<222> 1..22
<223> /mol_type="DNA"
      /note="HBD2 forward primer"
      /organism="artificial sequences"

<400> 3
ttcctgatgc ctcttccagt tt                                             22


<210> 4
<211> 23
<212> DNA
<213> artificial sequences

<220> 
<221> source
<222> 1..23
<223> /mol_type="DNA"
      /note="HBD2 reverse primer"
      /organism="artificial sequences"

<400> 4
ggatgacata tggctccact ctt                                            23


<210> 5
<211> 23
<212> DNA
<213> artificial sequences

<220> 
<221> source
<222> 1..23
<223> /mol_type="DNA"
      /note="LL-37 forward primer"
      /organism="artificial sequences"

<400> 5
tcaccagagg attgtgactt caa                                            23


<210> 6
<211> 21
<212> DNA
<213> artificial sequences

<220> 
<221> source
<222> 1..21
<223> /mol_type="DNA"
      /note="LL-37 reverse primer"
      /organism="artificial sequences"

<400> 6
tgagggtcac tgtccccata c                                              21


